Low level of cross-resistance between triclosan and antibiotics in Escherichia coli K-12 and E. coli O55 compared to E. coli O157

FEMS Microbiology Letters

Volumn 235, Issue 2, 2004, Pages 305-309

  Braoudaki, Maria ^a   Hilton, Anthony Craig ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

Antibiotic; Biocide; Escherichia coli; Resistance; Triclosan

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BENZALKONIUM CHLORIDE; CHLORAMPHENICOL; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; FUSIDIC ACID; GENTAMICIN; RIFAMPICIN; TETRACYCLINE; TRICLOSAN; TRIMETHOPRIM; VANCOMYCIN;

ADAPTATION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; CROSS RESISTANCE; ESCHERICHIA COLI; ESCHERICHIA COLI K 12; ESCHERICHIA COLI O157; ESCHERICHIA COLI O55; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ADAPTATION, PHYSIOLOGICAL; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; HUMANS; MICROBIAL SENSITIVITY TESTS; TRICLOSAN;

ESCHERICHIA COLI; ESCHERICHIA COLI K12;

EID: 2942583970     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.04.049     Document Type: Article

References (22)

1. Schweizer H.P. Triclosan: a widely used biocide and its link to antibiotics. FEMS Microbiol. Lett. 202:2001;1-7
2. McMurry L.M., Oethinger M., Levy S.B. Triclosan targets lipid synthesis. Nature. 394:1998;531-532
3. Larkin M. A close look at triclosan raises questions. Lancet. 353:1999;1160
4. Bhargava H.N., Leonard P.A. Triclosan: applications and safety. Am. J. Infect. Control. 4:1996;209-218
5. Chuanchuen R., Beinlich K., Hoand T.T., Becher A., Karkhoff-Schweizer R.R., Schweizer H. Cross-resistance between triclosan and antibiotics in Pseudomonas aeruginosa is mediated by multidrug efflux pumps: Exposure of a susceptible mutant strain to triclosan selects nfx mutants overexpressing MexCD-OprJ. J. Antimicrob. Agents Chemother. 45:2001;428-432
6. McMurry L.M., Oethinger M., Levy S.B. Overexpression of marA, SoxS, or acrAB produces resistance to triclosan in laboratory and clinical strains of Escherichia coli. FEMS Microbiol. Lett. 166:1998;305-309
7. Levy S.B. Antibacterial household products: cause for concern. Emerg. Infect. Dis. 7:2002;512-515
8. Braoudaki M., Hilton A.C. Adaptive resistance to biocides in Salmonella enterica and Escherichia coli O157 and cross-resistance to antimicrobial agents. J. Clin. Microbiol. 2004;42
9. Russell A.D. Introduction of biocides into clinical practice and the impact on antibiotic resistant bacteria. J. Appl. Microbiol. Symp. Suppl. 92:2002;121S-135S
10. Maillard J.-Y. Bacterial target sites for biocide action. J. Appl. Microbiol. Symposium Suppl. 92:2002;16S-27S
11. Tattawasart U., Maillard J.-Y., Furr J.R., Russell A.D. Development of resistance to chlorohexidine diacetate and cetylpyridinium chloride in Pseudomonas stutzeri and changes in antibiotic susceptibility. J. Hosp. Infect. 42:1999;219-229
12. Poole K. Mechanisms of bacterial biocides and antibiotic resistance. J. Appl. Microbiol. Symposium Suppl. 92:2002;55S-64S
13. Nikaido H., Basina M., Nguyen V., Rosenberg E. Muiltdrug efflux pumps AcrAB of Salmonella typhimurium excretes only those β-lactam antibiotics containing lipophilic side chains. J. Bacteriol. 180:1998;4686-4692
14. Levy S.B. Active efflux, a common mechanism for biocide and antibiotic resistance. J. Appl. Microbiol. Symposium Suppl. 92:2002;65S-71S
15. Eisen J.A. Gastrogenomics. Nature. 409:2001;463-466
16. National Committee for Clinical Laboratory Standards. (1997) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, PA
17. Hopkins K.L., Hilton A.C. Optimisation of ramdom amplification of polymorphic DNA analysis for molecular subtyping of Escherichia coli O157. Lett. Appl. Microbiol. 32:2001;126-130
18. British Society for Antimicrobial Chemotherapy. (1991) Journal of Antimicrobial Chemotherapy, vol. 27, suppl. D. Guide to sensitivity testing, Academic Press, London, UK
19. Perna N.T., Plunket G. III, Burland V., Mau B., Glasner J.D., Rose D.J., Mayhew G.F., Evans P.S., Gregor J., Kirkpatrick H.A., Posfai G., Hackett J., Klink S., Boutin A., Shao Y., Miller L., Grotbeck E.J., Davis N.W., Lim A., Dimalanta E.T., Potamousis K.D., Apodaka J., Anatharaman T.S., Lin J., Yen G., Schwartz D.C., Welch R.A., Blattner F.R. Genome sequence of enterohaemorrhagic Escherichia coli O157:H7. Lett. Nature. 409:2001;529-533
20. Whittam T.S., Wachsmuth I., Wilson R. Genetic evidence of clonal descent of Escherichia coli O157:H7 associated with haemorrhagic colitis and haemolytic ureamic syndrome. J. Infect. Dis. 157:1998;1124-1133
21. LeClerc J.E., Li B., Payne W.L., Cebula T.A. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science. 274:1996;1208-1211
22. Whittam T.S., Reid S.S., Selander R.K. Mutators and long-term molecular evolution of pathogenic Escherichia coli O157:H7. Emerg. Infect. Dis. 4:1998;615-617